IAP antagonization promotes inflammatory destruction of vascular endothelium by Axel Witt, Jens M Seeger, Oliver Coutelle, Paola Zigrino, Pia Broxtermann,

Slides:



Advertisements
Similar presentations
NgBR is essential for endothelial cell glycosylation and vascular development by Eon Joo Park, Kariona A Grabińska, Ziqiang Guan, and William C Sessa EMBO.
Advertisements

Induction of cyclin E–cdk2 kinase activity, E2F ‐ dependent transcription and cell growth by Myc are genetically separable events by Rudolf Beier, Andrea.
Ca 2+ ‐ independent insulin exocytosis induced by α ‐ latrotoxin requires latrophilin, a G protein ‐ coupled receptor by Jochen Lang, Yuri Ushkaryov, Alfonso.
Mutations in RNAs of both ribosomal subunits cause defects in translation termination by Alexey L. Arkov, David V. Freistroffer, Måns Ehrenberg, and Emanuel.
A brain microvasculature endothelial cell ‐ specific viral vector with the potential to treat neurovascular and neurological diseases by Jakob Körbelin,
Cell Physiol Biochem 2016;40: DOI: /
Fig. 3. ATME inhibits VEGF-induced invasion and tube formation of endothelial cells. (A) Effect of ATME on HUVEC invasion by using the Transwell culture.
Antitumor effect of the combination of IL-2 IC and anti–CTLA-4.
Selinexor combines with immune checkpoint blockade to slow B16F10 melanoma tumor growth. Selinexor combines with immune checkpoint blockade to slow B16F10.
Volume 15, Issue 6, Pages (June 2009)
Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells by Toshihiko Tanno, Yiting Lim, Qiuju.
Skovseth et al. Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. Blood.
Angiopoietin-1 promotes endothelial differentiation from embryonic stem cells and induced pluripotent stem cells by Hyung Joon Joo, Honsoul Kim, Sang-Wook.
A humanized single-chain antibody against beta 3 integrin inhibits pulmonary metastasis by preferentially fragmenting activated platelets in the tumor.
Stromal Fibroblast–Specific Expression of ADAM-9 Modulates Proliferation and Apoptosis in Melanoma Cells In Vitro and In Vivo  Anna N. Abety, Jay W. Fox,
Regulation of tumor angiogenesis by integrin-linked kinase (ILK)
Imiquimod Inhibits Melanoma Development by Promoting pDC Cytotoxic Functions and Impeding Tumor Vascularization  Caroline Aspord, Laetitia Tramcourt,
Christian M. Becker, M. D. , David A. Sampson, B. A. , Maria A
Combined A2A receptor and PD-1 blockade is not effective in IFNγ−/− mice. Combined A2A receptor and PD-1 blockade is not effective in IFNγ−/− mice. AT-3ovadim.
H31m1-PDL1 cells form progressively growing tumors in WT mice.
Fig. 5 A competent Fc is required for the antitumor immune response.
DQ661 improves survival in colon cancer model and potentiates activity of gemcitabine in KPC pancreatic cancer syngeneic model. DQ661 improves survival.
HER2 mutants V777L, G309A, D769H formed tumors more rapidly than HER2 WT. A, a total of 0.5 × 106 cells of NIH3T3 expressing either HER2 WT or mutant were.
Peritumoral injections of poly(I:C) induce type I IFN–dependent cytotoxic immunity and delay the growth of primary and transplanted Hgf-Cdk4R24C melanomas.
Volume 9, Issue 3, Pages (March 2006)
Merlin-deficient RAS-mutant cells and murine PDTCs are more sensitive to MEK inhibition. Merlin-deficient RAS-mutant cells and murine PDTCs are more sensitive.
Nicholas D. James, Jim W. Growcott  European Urology Supplements 
Volume 3, Issue 2, Pages (February 2001)
Volume 22, Issue 3, Pages (March 2012)
In vivo efficacy of Olaparib in PTEN deficient xenografts.
TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways  Hailing Hsu, Hong-Bing Shu, Ming-Gui Pan, David.
Stroke induces inflammatory activation of the aortic endothelium
Volume 26, Issue 5, Pages e6 (January 2019)
Pharmacologic inhibition of eIF5A hypusination sensitizes KRas-driven tumor cells to MEK and KRas inhibition. Pharmacologic inhibition of eIF5A hypusination.
Inhibiting or altering the timing of microbial antigen encounter results in inflammatory T cell responses against gut bacteria. Inhibiting or altering.
Administration of necroptosis-targeting AAVs in conjunction within vivo promotes durable tumor clearance. Administration of necroptosis-targeting AAVs.
Expression and Activity of Methylation-Associated Proteins In Vivo and In Vitro (AandB) The protein level of methylation-associated proteins (DNMT1, DNMT3a,
NOX1-deficient mice do not respond to GKT771 and exhibit reduced B16-F10 tumor growth associated with decreased production of angiogenic factors and minor.
PD1 targeting alters the recruitment of immune cells to MC38 CRC tumors. PD1 targeting alters the recruitment of immune cells to MC38 CRC tumors. MC38.
NK Cells Fighting Cancer
In vivo assessment of synergistic activity of MV-CEA and RT in a U87 s
coTCRcys-transduced T cells control tumor growth in vivo.
Augmentation of in vivo CMS5mHE tumor eradication by HER216-30, but not OVA Augmentation of in vivo CMS5mHE tumor eradication by HER216-30, but.
EHop-016 and INK128 treatment of myxofibrosarcoma xenografts in NSG mice. EHop-016 and INK128 treatment of myxofibrosarcoma xenografts in NSG mice. A,
PRIMA-1Met inhibits the growth of multiple myeloma tumors with mutant p53 in vivo. PRIMA-1Met inhibits the growth of multiple myeloma tumors with mutant.
Anti-Flk-1 treatment inhibits growth of s. c. 4T1 and B16 tumors. s. c
Matriptase-2 inhibited breast tumor development in vivo.
The effect of IAA on tumor growth in an SK-MEL-28 xenograft model.
Bcl-2 and caspase inhibition fails to inhibit BAMLET-induced cytotoxicity in MCF-7 cells. Bcl-2 and caspase inhibition fails to inhibit BAMLET-induced.
Bcl-xL expression in tumors antagonizes the therapeutic efficiency of ERBB2 downregulation. Bcl-xL expression in tumors antagonizes the therapeutic efficiency.
PD-L1 expressed on edited T3 sarcoma cells prevents their immune elimination. PD-L1 expressed on edited T3 sarcoma cells prevents their immune elimination.
Endogenously produced n-3 PUFAs inhibit endometrial cancer cell growth in vitro and in vivo. Endogenously produced n-3 PUFAs inhibit endometrial cancer.
Effect of inhibiting HO-1 on adaptive immune- and cytokine-dependent regulation of tumor growth. Effect of inhibiting HO-1 on adaptive immune- and cytokine-dependent.
Impact of eNOS expression and treatment with GSNO on prostate tumor growth. Impact of eNOS expression and treatment with GSNO on prostate tumor growth.
Pdcd4 expression inhibits AP-1 transactivation.
Comparison of in vivo activity of 4D5scFvZZ and 4D5scFv.
Tumor protection induced by therapeutic PLG vaccination in combination with blockade antibodies. Tumor protection induced by therapeutic PLG vaccination.
MGA271 exhibits potent in vivo antitumor activity toward tumor cell carcinoma xenografts. MGA271 exhibits potent in vivo antitumor activity toward tumor.
BMX inhibition suppresses the growth of CRPC cells in vitro and in vivo. BMX inhibition suppresses the growth of CRPC cells in vitro and in vivo. A, CWR22RV1.
Targeting GAPLINC decreased CD44 expression and tumor growth in vivo.
Proliferation of TA3-Ha and TA3-St cells in vitro and in vivo.
BMX is a driver of castration resistance in vitro and in vivo.
MYC expression is correlated with dasatinib sensitivity in cancer cell lines and in vivo. MYC expression is correlated with dasatinib sensitivity in cancer.
Cabozantinib causes significant tumor cell elimination in vivo, but modest apoptosis induction in vitro. Cabozantinib causes significant tumor cell elimination.
Validation of KMT2D function in MM23, MM2, and MM25 PDXs
Curative effect of W+T treatment in vivo.
NSD2-mediated methylation of PTEN at K349 dictates cellular sensitivity to DNA-damaging agents. NSD2-mediated methylation of PTEN at K349 dictates cellular.
MET activation confers resistance to cetuximab (Cmab) or panitumumab (Pmab) in colon cancer cell lines in vitro and in vivo. MET activation confers resistance.
Knockdown of ROR1 increases the invasive potential of melanoma cells in vitro and in vivo. Knockdown of ROR1 increases the invasive potential of melanoma.
Parthenolide inhibits tumor promotion and increases p21 expression in vivo. Parthenolide inhibits tumor promotion and increases p21 expression in vivo.
Presentation transcript:

IAP antagonization promotes inflammatory destruction of vascular endothelium by Axel Witt, Jens M Seeger, Oliver Coutelle, Paola Zigrino, Pia Broxtermann, Maria Andree, Kerstin Brinkmann, Christian Jüngst, Astrid C Schauss, Stephan Schüll, Dirk Wohlleber, Percy A Knolle, Martin Krönke, Cornelia Mauch, and Hamid Kashkar EMBO Rep. Volume ():e March 30, 2015 ©2015 by European Molecular Biology Organization

Comp A inhibits B16 melanoma growth in vivo Growth rates of B16 tumors mixed with matrigel and vehicle (control) or Comp A (2 μM) and subcutaneously injected into the flank region of recipient mice. Axel Witt et al. EMBO Rep. doi: /embr ©2015 by European Molecular Biology Organization

Comp A inhibits B16 tumor growth in vivo The murine melanoma cell line B16 was mixed with matrigel and vehicle (control) or Comp A (2 μM) and then subcutaneously injected into the flank region of recipient mice. Axel Witt et al. EMBO Rep. doi: /embr ©2015 by European Molecular Biology Organization

Comp A inhibits tumor vasculature in vivo B16 cells were mixed with matrigel and vehicle (control) or Comp A (2 μM) and subcutaneously injected into the flank region of recipient mice. Axel Witt et al. EMBO Rep. doi: /embr ©2015 by European Molecular Biology Organization

Comp A inhibits B16 tumor vasculature in vivo without altering immune cell infiltrationThe murine melanoma cell line B16 was mixed with matrigel and vehicle (control) or Comp A (2 μM) and then subcutaneously injected into the flank region of recipient mice... Axel Witt et al. EMBO Rep. doi: /embr ©2015 by European Molecular Biology Organization

Comp A promotes TNF ‐ induced endothelial cell death HUVEC and HDMEC cells were treated with increasing amounts of Comp A or Comp B alone or in combination with TNF (20 ng/ml). Axel Witt et al. EMBO Rep. doi: /embr ©2015 by European Molecular Biology Organization

Comp A promotes TNF ‐ induced endothelial cell death Measurement of clonogenicity of HUVEC cells treated as indicated. Axel Witt et al. EMBO Rep. doi: /embr ©2015 by European Molecular Biology Organization

Comp A potentiates TNF ‐ dependent vascular disruption in vivo A, BMatrigel was mixed with vehicle (control), Comp A (2 μM), or TNF (50 ng/ml) and subcutaneously injected into the flank region of recipient wild ‐ type mice (A) or TNFR ‐ 1/2−/− mice (B). Axel Witt et al. EMBO Rep. doi: /embr ©2015 by European Molecular Biology Organization

IAP antagonization potentiates TNF ‐ induced vascular disruption in vivoMatrigel was mixed with vehicle (control) or Comp A (2 μM) and subcutaneously injected into the flank region of recipient TNFR ‐ 1/2−/− mice. Axel Witt et al. EMBO Rep. doi: /embr ©2015 by European Molecular Biology Organization